Published in Cancer on January 15, 1992
Increased beta-catenin protein and somatic APC mutations in sporadic aggressive fibromatoses (desmoid tumors). Am J Pathol (1997) 2.34
Chromosomal aberrations in soft tissue tumors. Relevance to diagnosis, classification, and molecular mechanisms. Am J Pathol (1994) 1.60
Trisomies 8 and 20 characterize a subgroup of benign fibrous lesions arising in both soft tissue and bone. Am J Pathol (1999) 1.21
Mutations of adenomatous polyposis coli (APC) gene are uncommon in sporadic desmoid tumours. Br J Cancer (1998) 0.96
Mesenteric fibromatosis with intestinal involvement mimicking a gastrointestinal stromal tumour. Radiol Oncol (2010) 0.90
Desmoid tumours of the extremities and trunk: a review of the literature. Int Orthop (2005) 0.84
Huge intrathoracic desmoid tumor. Ann Thorac Med (2009) 0.83
Simultaneous interphase cytogenetic analysis and fluorescence immunophenotyping of dedifferentiated chondrosarcoma. Implications for histopathogenesis. Am J Pathol (1994) 0.81
Incidental Finding and Management of Mesenteric Fibromatosis. Am J Case Rep (2016) 0.79
CD99-positive soft tissue sarcoma with chromosomal translocation between 1 and 16 and inversion of chromosome 5. Oncol Lett (2012) 0.76
[Desmoid tumors of the chest wall: report of 12 cases]. Pan Afr Med J (2009) 0.75
[Aggressive fibromatosis in the jaw and facial region with bone involvement. A review]. Mund Kiefer Gesichtschir (2005) 0.75
Isolation and characterization of a spontaneously immortalized human breast epithelial cell line, MCF-10. Cancer Res (1990) 9.85
Malignant MCF10CA1 cell lines derived from premalignant human breast epithelial MCF10AT cells. Breast Cancer Res Treat (2001) 3.77
HER-2/neu gene amplification characterized by fluorescence in situ hybridization: poor prognosis in node-negative breast carcinomas. J Clin Oncol (1997) 3.66
Rearrangement of the MLL gene in acute lymphoblastic and acute myeloid leukemias with 11q23 chromosomal translocations. N Engl J Med (1993) 3.37
Xenograft model of progressive human proliferative breast disease. J Natl Cancer Inst (1993) 3.03
The LNCaP cell line--a new model for studies on human prostatic carcinoma. Prog Clin Biol Res (1980) 2.97
Prognostic impact of P53 status, TLS-CHOP fusion transcript structure, and histological grade in myxoid liposarcoma: a molecular and clinicopathologic study of 82 cases. Clin Cancer Res (2001) 2.80
Gardner syndrome in a man with an interstitial deletion of 5q. Am J Med Genet (1986) 2.78
MCF10AT: a model for the evolution of cancer from proliferative breast disease. Am J Pathol (1996) 2.62
Susceptibility of Fanconi's anaemia fibroblasts to chromosome damage by carcinogens. Nature (1976) 2.24
The journal "impact factor": a misnamed, misleading, misused measure. Cancer Genet Cytogenet (1998) 2.23
Relationship of chemotherapy-induced necrosis and surgical margins to local recurrence in osteosarcoma. J Clin Oncol (1994) 2.20
Race and differences in breast cancer survival in a managed care population. J Natl Cancer Inst (1999) 2.06
Development of a disease specific quality of life (QoL) questionnaire module to supplement the EORTC core cancer QoL questionnaire, the QLQ-C30 in patients with pancreatic cancer. EORTC Study Group on Quality of Life. Eur J Cancer (1999) 1.99
Culture of human leukemia cells. Cancer (1966) 1.94
Common clonal origin of synchronous primary head and neck squamous cell carcinomas: analysis by tumor karyotypes and fluorescence in situ hybridization. Hum Pathol (1995) 1.91
Disappearance of a structural chromatin protein A24 in mitosis: implications for molecular basis of chromatin condensation. Proc Natl Acad Sci U S A (1979) 1.91
NM1 keratinocyte line is cytogenetically and biologically stable and exhibits a unique structural protein. J Invest Dermatol (1987) 1.83
Xenografts of primary human prostatic carcinoma. J Natl Cancer Inst (1993) 1.80
Characterization of a new primary human pancreatic tumor line. Cancer Invest (1986) 1.67
Arthrodesis of the knee with a modular titanium intramedullary nail. J Bone Joint Surg Am (1997) 1.66
Adamantinoma-like Ewing's sarcoma: genomic confirmation, phenotypic drift. Am J Surg Pathol (1999) 1.61
Amplification of the c-myb oncogene in a case of human acute myelogenous leukemia. Science (1984) 1.56
Evidence for the clonal origin of spontaneous metastases. Science (1982) 1.52
Hereditary nonpolyposis colorectal cancer (Lynch syndromes I and II). II. Biomarker studies. Cancer (1985) 1.51
Application of long-term collagenase disaggregation for the cytogenetic analysis of human solid tumors. Cancer Genet Cytogenet (1986) 1.49
Hereditary nonpolyposis colorectal cancer (Lynch syndromes I and II). I. Clinical description of resource. Cancer (1985) 1.48
Isopeptidase: a novel eukaryotic enzyme that cleaves isopeptide bonds. Proc Natl Acad Sci U S A (1982) 1.47
Cytogenetic findings in a primary malignant fibrous histiocytoma of bone and the lung metastasis. Pathology (1990) 1.44
Convention on nomenclature for DNA cytometry. Committee on Nomenclature, Society for Analytical Cytology. Cancer Genet Cytogenet (1984) 1.42
Genetic markers in thyroid tumors. Surgery (1991) 1.39
Trisomy 14: a new entity within acute nonlymphocytic leukemia. Cancer Genet Cytogenet (1989) 1.39
Involvement of 6p in benign lipomas. A new cytogenetic entity? Cancer Genet Cytogenet (1989) 1.39
Comparison of computed tomography and other imaging modalities in the evaluation of musculoskeletal tumors. Radiology (1979) 1.35
A recurring translocation, t(11;22)(p13;q11.2), characterizes intra-abdominal desmoplastic small round-cell tumors. Cancer Genet Cytogenet (1993) 1.35
Giant-cell tumor of bone in skeletally immature patients. J Bone Joint Surg Am (1983) 1.31
Parosteal lipoma: MR imaging characteristics. AJR Am J Roentgenol (1994) 1.31
Hybridization of nuclear matrix attached deoxyribonucleic acid fragments. Biochemistry (1981) 1.26
Translocation X;18 in synovial sarcoma. Cancer Genet Cytogenet (1986) 1.26
Cytogenetic findings in 73 osteosarcoma specimens and a review of the literature. Cancer Genet Cytogenet (1997) 1.25
Allelic loss in locally metastatic, multisampled prostate cancer. Cancer Res (1994) 1.24
Translocation t(1;3)(p36.3;q25) is a nonrandom aberration in epithelioid hemangioendothelioma. Am J Surg Pathol (2001) 1.24
Cytogenetic studies of tumor tissue from patients with nonfamilial renal cell carcinoma. Cancer Res (1986) 1.22
Trisomies 8 and 20 characterize a subgroup of benign fibrous lesions arising in both soft tissue and bone. Am J Pathol (1999) 1.21
Biologic and clinical significance of cytogenetic and molecular cytogenetic abnormalities in benign and malignant cartilaginous lesions. Cancer Genet Cytogenet (1993) 1.21
Quantitative conservation of chromatin-bound RNA polymerases I and II in mitosis. Implications for chromosome structure. J Cell Biol (1979) 1.20
Involvement of chromosome X in primary cytogenetic change in human neoplasia: nonrandom translocation in synovial sarcoma. Proc Natl Acad Sci U S A (1987) 1.20
Cytogenetic studies of adipose tissue tumors. II. Recurrent reciprocal translocation t(12;16)(q13;p11) in myxoid liposarcomas. Cancer Genet Cytogenet (1986) 1.19
Prognostic significance of histopathologic response to chemotherapy in nonmetastatic Ewing's sarcoma of the extremities. J Clin Oncol (1993) 1.19
The chromosomes and causation of human cancer and leukemia. Cancer Res (1966) 1.19
Cytogenetic findings in liposarcoma correlate with histopathologic subtypes. Cancer (1992) 1.18
Giant cell tumor of bone. Chromosomal analysis of 48 specimens and review of the literature. Cancer Genet Cytogenet (1992) 1.17
Increased sister chromatid exchange in bone marrow and blood cells from Bloom's syndrome. Cytogenet Cell Genet (1976) 1.17
Induction of prophase in interphase nuclei by fusion with metaphase cells. J Cell Biol (1972) 1.16
Isolation and characterization of a spontaneously arising long-lived line of human keratinocytes (NM 1). In Vitro Cell Dev Biol (1987) 1.14
Steroid receptors in exocrine glands: the pancreas and prostate. J Steroid Biochem (1979) 1.12
Direct action of estrogen on sequence of progression of human preneoplastic breast disease. Am J Pathol (1998) 1.12
The biology of breast cancer at the cellular level. Biochim Biophys Acta (1984) 1.11
Three possible cytogenetic subgroups of leiomyosarcoma. Cancer Genet Cytogenet (1989) 1.11
Suppression of the response of lymphocytes to phytohemagglutinin in rubella. J Infect Dis (1974) 1.10
Chromosomal abnormalities in human neoplasia. Annu Rev Med (1970) 1.10
Genetic changes in epithelial solid neoplasia. Cancer Res (1994) 1.10
Chromosome pulverization in human binucleate cells following colcemid treatment. J Cell Biol (1967) 1.09
Pubic and sacral insufficiency fractures: clinical course and radiologic findings. AJR Am J Roentgenol (1985) 1.09
BCL3 rearrangements and t(14;19) in chronic lymphocytic leukemia and other B-cell malignancies: a molecular and cytogenetic study. Genes Chromosomes Cancer (1997) 1.08
Chromosomal abnormalities in leiomyosarcomas. Am J Pathol (1993) 1.07
Chromosomes and causation of human cancer and leukemia: XL. The Ph1 and other translocations in CML. Cancer (1980) 1.07
Immortalization in culture: occurrence at a late stage in the progression of breast cancer. J Natl Cancer Inst (1987) 1.07
Chromosomes and causation of human cancer and leukemia. II. Karyotypes of human solid tumors. Cancer (1966) 1.07
Cytogenetic characterization of putative human myeloblastic leukemia cell lines (ML-1, -2, and -3): origin of the cells. Cancer Res (1986) 1.06
Cytogenetic analysis of dermatofibrosarcoma protuberans. Cancer Genet Cytogenet (1990) 1.06
Survivorship analysis of VSP spine instrumentation in the treatment of thoracolumbar and lumbar burst fractures. Spine (Phila Pa 1976) (1991) 1.06
Hermansky-Pudlak syndrome: a clinicopathologic study. Hum Pathol (1985) 1.06
Sex chromosome aneuploidy and aging. Mutat Res (1995) 1.05
Elevated superoxide dismutase in Bloom's syndrome: a genetic condition of oxidative stress. Cancer Res (1989) 1.05
Chronology and pattern of human chromosome replication, IV. Autoradiographic studies of binucleate cells. Proc Natl Acad Sci U S A (1966) 1.05
Translocation (X;1) in papillary renal cell carcinoma. A new cytogenetic subtype. Cancer Genet Cytogenet (1993) 1.05
Genetic instability coupled to clonal selection as a mechanism for tumor progression in the Dunning R-3327 rat prostatic adenocarcinoma system. Cancer Res (1982) 1.04
Chromosomal aneuploidy in proliferative breast disease. Hum Pathol (1994) 1.04
Surgical treatment of giant-cell tumor of the spine. The experience at the Istituto Ortopedico Rizzoli. J Bone Joint Surg Am (1983) 1.03
Characterization of the breakpoint of a t(14;14)(q11.2;q32) from the leukemic cells of a patient with T-cell acute lymphoblastic leukemia. Cancer Genet Cytogenet (1990) 1.03
Induction of nuclear envelopes around metaphase chromosomes after fusion with interphase cells. J Cell Biol (1971) 1.03
Chromosome pulverization in chinese hamster cells induced by Sendai virus. J Natl Cancer Inst (1968) 1.03
Molecular approaches to identification of tissue contamination in surgical pathology sections. J Mol Diagn (2001) 1.03
Relation of virus-induce cell fusion and chromosome pulverization to mitotic events. J Natl Cancer Inst (1969) 1.02
The MCF10 family of spontaneously immortalized human breast epithelial cell lines: models of neoplastic progression. Eur J Cancer Prev (1993) 1.01
Phenotypic similarities and differences between CALLA-positive acute lymphoblastic leukemia cells and normal marrow CALLA-positive B cell precursors. Blood (1987) 1.01
Aneuploidy and age in a population survey. Am J Hum Genet (1967) 1.01
Philadelphia-chromosome-positive and -negative chronic myelocytic leukemia. Ann Intern Med (1970) 1.01
Electron microscopic study of fused cells, with special reference to chromosome pulvrization. J Natl Cancer Inst (1970) 1.01
Fanconi's anemia with growth hormone deficiency. J Pediatr (1971) 1.01
Recurrent chromosomal imbalances and structurally abnormal breakpoints within complex karyotypes of malignant peripheral nerve sheath tumour and malignant triton tumour: a cytogenetic and molecular cytogenetic study. J Clin Pathol (2004) 1.00
Misexpression of disrupted HMGI architectural factors activates alternative pathways of tumorigenesis. Cancer Res (1997) 1.00
Clonal chromosomal abnormalities in osteofibrous dysplasia. Implications for histopathogenesis and its relationship with adamantinoma. Cancer (1994) 0.99
Chromosome aberrations in individuals occupationally exposed to ethylene oxide, and in a large control population. Mutat Res (1986) 0.99
Two discrete regions of deletion at 7q in uterine leiomyomas. Genes Chromosomes Cancer (1997) 0.99
Trisomy 6 as a primary karyotypic aberration in hematologic disorders. Cancer Genet Cytogenet (1998) 0.98
Chromosomal aberrations identified in culture of squamous carcinomas are confirmed by fluorescence in situ hybridisation. Mol Pathol (1999) 0.98